REQUEST A DEMO
Total
USD $0.00
Search more companies

Star Pharmaceutical Limited (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Star Pharmaceutical Limited Profile Updated: December 22, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English Download a sample report

Star Pharmaceutical Limited is engaged in manufacturing and sale of both Western and TCM-formulated prescription drugs, focusing primarily on antibiotics, cardiovascular drugs and cerebrovascular drugs. The company's products includes antibiotics, cerebrovascular drugs and cardiovascular drugs, and other specialised drugs manufactured inhouse in various dosages and administration forms from powder injections, lyophilized powder injections, liquid injections to tablets, capsules and granules. Star Pharmaceutical distribute its products to hospitals, clinics and pharmacies in China. The company was incorporated in 2005..

Legal Address
Dalu Town, Qionghai City,Hainan Province
Hainan; Qinghai; Postal Code: 571425

Contact Details: Purchase the Star Pharmaceutical Limited report to view the information.

Website: http://www.hnstar.com.cn

Basic Information
Outstanding Shares:
Purchase the Star Pharmaceutical Limited report to view the information.
Financial Auditors:
Purchase the Star Pharmaceutical Limited report to view the information.
Incorporation Date:
2005
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Ownership Details
Purchase this report to view the information.
6.47%
Company Performance
Financial values in the chart are available after Star Pharmaceutical Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
77.94%
Total operating revenue
75.85%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
32.45%
Total equity
-7.34%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.28%
Cash Ratio
-0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?